Rhumbline Advisers Has $22.36 Million Stake in Globe Life Inc. (NYSE:GL)

Rhumbline Advisers decreased its position in Globe Life Inc. (NYSE:GL - Free Report) by 4.2% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 200,487 shares of the company's stock after selling 8,786 shares during the quarter. Rhumbline Advisers owned about 0.24% of Globe Life worth $22,358,000 as of its most recent filing with the SEC.

A number of other large investors have also recently added to or reduced their stakes in GL. State Street Corp lifted its holdings in shares of Globe Life by 3.4% during the third quarter. State Street Corp now owns 3,545,272 shares of the company's stock worth $375,480,000 after buying an additional 115,432 shares during the last quarter. Principal Financial Group Inc. lifted its holdings in shares of Globe Life by 9.0% during the third quarter. Principal Financial Group Inc. now owns 105,315 shares of the company's stock worth $11,154,000 after buying an additional 8,663 shares during the last quarter. Merit Financial Group LLC acquired a new position in shares of Globe Life during the fourth quarter worth approximately $487,000. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Globe Life by 85.9% during the third quarter. Wealth Enhancement Advisory Services LLC now owns 19,779 shares of the company's stock worth $2,095,000 after buying an additional 9,141 shares during the last quarter. Finally, Pacer Advisors Inc. lifted its holdings in shares of Globe Life by 56.0% during the fourth quarter. Pacer Advisors Inc. now owns 10,199 shares of the company's stock worth $1,137,000 after buying an additional 3,662 shares during the last quarter. Institutional investors own 81.61% of the company's stock.

Wall Street Analyst Weigh In

GL has been the subject of a number of research analyst reports. Jefferies Financial Group upped their price target on Globe Life from $107.00 to $114.00 and gave the stock a "hold" rating in a report on Tuesday, December 10th. BMO Capital Markets initiated coverage on Globe Life in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $114.00 target price for the company. Morgan Stanley upped their target price on Globe Life from $123.00 to $125.00 and gave the company an "equal weight" rating in a research note on Tuesday, February 11th. Evercore ISI upgraded Globe Life from an "in-line" rating to an "outperform" rating and upped their target price for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. Finally, Wells Fargo & Company upped their target price on Globe Life from $126.00 to $141.00 and gave the company an "overweight" rating in a research note on Wednesday. Five investment analysts have rated the stock with a hold rating, five have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Globe Life presently has a consensus rating of "Moderate Buy" and a consensus price target of $135.50.

Insider Transactions at Globe Life

In other news, CMO Jennifer Allison Haworth sold 9,000 shares of the stock in a transaction on Monday, January 6th. The stock was sold at an average price of $112.91, for a total transaction of $1,016,190.00. Following the sale, the chief marketing officer now owns 13,485 shares in the company, valued at approximately $1,522,591.35. This represents a 40.03 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Frank M. Svoboda sold 14,340 shares of the stock in a transaction on Tuesday, December 3rd. The stock was sold at an average price of $108.80, for a total value of $1,560,192.00. Following the sale, the chief executive officer now owns 16,396 shares in the company, valued at $1,783,884.80. The trade was a 46.66 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 75,678 shares of company stock worth $8,799,822. Insiders own 1.51% of the company's stock.

Globe Life Price Performance

Globe Life stock traded down $1.75 during mid-day trading on Friday, hitting $122.52. 626,701 shares of the company were exchanged, compared to its average volume of 584,418. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The business has a fifty day moving average of $116.19 and a 200 day moving average of $108.83. Globe Life Inc. has a 1-year low of $38.95 and a 1-year high of $132.00. The company has a market capitalization of $10.28 billion, a PE ratio of 10.25 and a beta of 0.81.

Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings data on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. As a group, sell-side analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.

About Globe Life

Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.